A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2011
09/14/2011	EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011	EP1689362B1 Pharmaceutical compounding systems and methods and information management system for same
09/14/2011	EP1631234B1 Compositions and methods for the treatment of cns injuries
09/14/2011	EP1563301B1 Vaccine for the prevention of malaria
09/14/2011	EP1501895B1 Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
09/14/2011	CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
09/13/2011	US8017760 Antisense modulation of PTP1B expression
09/13/2011	US8017641 P38 inhibitors and methods of use thereof
09/13/2011	US8017629 Compounds and uses thereof in modulating amyloid β
09/13/2011	US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2011	US8017161 Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
09/13/2011	US8017134 Recombinant toxin fragments
09/13/2011	US8017127 Influenza immunogen and vaccine
09/13/2011	CA2525873C Tumor cytotoxicity induced by modulators of the cxcr4 receptor
09/08/2011	US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function
09/08/2011	US20110217329 Vaccine
09/07/2011	EP2363493A1 Novel insertion sites in pox vectors
09/07/2011	EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient.
09/07/2011	EP2100605B1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
09/07/2011	CN1817882B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/07/2011	CN1787817B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions
09/07/2011	CN102172402A Carbostyril derivatives and mood stabilizers for treating mood disorders
09/07/2011	CN102172401A Carbostyril derivatives and mood stabilizers for treating mood disorders
09/06/2011	US8013170 Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage
09/06/2011	US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines
09/06/2011	US8012975 Antitumoral analogs of ET-743
09/06/2011	US8012943 Antibacterial agents
09/06/2011	US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing
09/06/2011	US8012696 Monoclonal antibody capable of binding integrin alpha 10 beta 1
09/06/2011	US8012479 Recombinant toxin fragments
09/06/2011	CA2449419C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
09/01/2011	US20110212843 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
08/2011
08/31/2011	EP2361966A1 Mesoderm and definitive endoderm cell populations
08/31/2011	EP2361928A1 Truncated fragments of alpha-synuclein in Lewy body disease
08/31/2011	EP1095140B1 Neurotrophic factors
08/31/2011	CN1863798B 2,4-dioxo-3-quinazolinylaryl sulfonylureas
08/31/2011	CN102166359A Carbostyril derivatives and mood stabilizers for treating mood disorders
08/30/2011	US8008469 Antisense compound for inducing immunological tolerance
08/30/2011	US8008450 Therapeutic use of anti-CS1 antibodies
08/30/2011	US8008315 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/30/2011	US8008265 Vaccines, immunotherapeutics and methods for using the same
08/30/2011	US8008258 Cop 1 for treatment of inflammatory bowel diseases
08/30/2011	US8008255 Methods and compositions for enhanced transmucosal delivery of peptides and proteins
08/30/2011	US8007997 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
08/30/2011	US8007782 Using spores of anaerobic bacteria and microtubules stabilization antitumor agents; destroying tumors
08/30/2011	CA2459757C Combination
08/25/2011	US20110207753 Methods for treating pain
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207659 Oligosaccharide compositions and use thereof in the treatment of infection
08/25/2011	US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206606 Stable radiopharmaceutical compositions and methods for preparation
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP1694311B1 Chewable soft capsules containing ungelatinized starch
08/24/2011	EP1587923B1 Improved constructs for expressing lysosomal polypeptides
08/24/2011	EP1545625B1 Flexible vaccine assembly and vaccine delivery platform
08/24/2011	CN102161679A Compositions and methods for treating cancer
08/24/2011	CN102160651A Stabilized formulations of phosphatidylserine
08/23/2011	US8003789 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
08/23/2011	US8003113 DNA vaccine compositions and methods of use
08/23/2011	US8003090 Method for inhibiting a microvascular complication by administering IL-6
08/18/2011	US20110201798 Therapeutic compositions
08/18/2011	US20110201692 Antimicrobial flush solutions
08/17/2011	EP2357189A2 AAV virions with decreased immunoreactivity and uses therefor
08/17/2011	EP1638509B1 Thermally stable crystalline epirubicin hydrochloride and method of making the same
08/17/2011	EP1599209B1 Inhalation composition
08/17/2011	EP1575531B1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta
08/17/2011	CN1897812B Glycopegylated granulocyte colony stimulating factor
08/17/2011	CN1787741B Methods and compositions for the prevention and treatment of sepsis
08/17/2011	CN102151330A Vaccine and method for treatment of motor neurone diseases
08/16/2011	US7998738 Integrin-binding antibodies
08/16/2011	US7998478 Pharmaceutical composition for treating immune diseases
08/11/2011	US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011	US20110196061 Initiators and crosslinkable polymeric materials
08/11/2011	US20110196043 Methods and compositions for administration of trpv1 agonists
08/10/2011	EP2354155A2 Fusion Proteins for Treatment of CNS
08/10/2011	EP2354125A1 Anhydrous and hydrate polymorphic forms of antihistaminic piperidine derivatives
08/10/2011	EP2353656A2 Functional fragrance precursor
08/10/2011	EP2353655A2 Functional fragrance precursor
08/10/2011	EP2353654A2 Functional fragrance precursor
08/10/2011	EP2353653A2 Functional fragrance precursor
08/10/2011	EP2353652A2 Functional fragrance precursor
08/10/2011	EP2353615A2 Compositions and methods for treating inflammatory lung disease
08/10/2011	EP2353606A2 Compositions and methods for the treatment of CNS injuries
08/10/2011	EP2353389A1 Methods and compositions for treating disorders
08/10/2011	EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
08/10/2011	CN101050445B Microbe for producing epothilone
08/09/2011	US7994116 Methods for reduction of adhesion formation using cytokine inhibitors
08/09/2011	CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2688708C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2542279C Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
08/09/2011	CA2539707C Quinoline potassium channel inhibitors
08/09/2011	CA2537092C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011	CA2334941C Tnf-derived peptides for use in treating oedema
08/04/2011	US20110190144 Novel compositions and methods for the treatment of psoriasis
08/04/2011	US20110185517 Epilatory compositions
08/03/2011	EP1675572B1 Coated metal pyrithione particles for treatment of microorganisms

1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 295